Study of the Use of Misoprostol to Decrease Bleeding During a Myomectomy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01700478|
Recruitment Status : Completed
First Posted : October 4, 2012
Last Update Posted : February 11, 2013
|Condition or disease||Intervention/treatment||Phase|
|Hemorrhage||Drug: Misoprostol + vasopressin Drug: Vasopressin||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||45 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Double (Participant, Care Provider)|
|Official Title:||A Trial Comparing The Use Of Rectal Plus Perivascular Vasopressin With Perivascular Vasopressin Alone To Decrease Bleeding At The Time Of Myomectomy|
|Study Start Date :||February 2005|
|Actual Primary Completion Date :||April 2005|
|Actual Study Completion Date :||April 2005|
Experimental: Misoprostol + vasopressin, Vasopressin
Misoprostol 400ug given rectally one hour before surgery.
Drug: Misoprostol + vasopressin
400ug of misoprostol is given per rectum, one hour prior to surgery. Vasopressin is used at the time of surgery.
Other Name: Cytotec
Vasopressin was used in all patients during surgery.
Other Name: Anti-diuretic hormone
- Blood loss in millilitres [ Time Frame: At the time of surgery ]
- A change in hemoglobin grams per decilitre [ Time Frame: At baseline and 24hours after surgery ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01700478
|University Hospital of the West Indies|
|Principal Investigator:||Sharifa K Frederick, dM||University Hospital of the West Indies|